Treatment of Hodgkin's lymphoma abroad seeks to maximize the risk-benefit ratio. Clinics in Israel, China, Germany, India, Singapore, Korea and Turkey focus on individual therapy. The most effective tool in this regard is immunotherapy, monoclonal antibodies. Clinical trials of newly developed revolutionary drugs are being actively conducted in hospitals in Germany and Israel.
Modern treatment of lymphogranulomatosis abroad
Treatment of Hodgkin's lymphoma abroad helps healthy cells fight cancer while minimizing the overall impact on the body. Advanced methods cause the least possible damage to the reproductive organs and the cardiovascular system.
Chemotherapy
Medications remain the main treatment for lymphogranulomatosis. Clinics in Korea, Turkey and China offer modern chemotherapy options with combinations of ABVD and BEACOPP of a less toxic dosage. During therapy, patients undergo PET-CT scans. These tests are used to monitor the lymphoma and check how well the treatment is working.
The optimal combination of drugs and the cost of safer chemotherapy is determined by the patient's disease parameters. Prices for treatment of Hodgkin's lymphoma abroad will also vary depending on the country.
Radiation therapy
Hospitals in China, Singapore and Korea offer the latest methods of radiation therapy.
- Intensive modulated radiation therapy helps to change the strength and direction of the rays, reducing the risk of damage to healthy tissues.
- Proton therapy uses protons, not X-rays. This increases the concentration of radiation in the tumor area without affecting the adjacent normal organs.
Immunotherapy
The treatment of lymphogranulomatosis abroad with the help of immunotherapy has achieved great success. Instead of attacking the disease, immune drugs help the body fight it on its own. This gives fewer side effects and a long-term positive result.
Modern methods of immunotherapy for Hodgkin's lymphoma include:
- antibody drug conjugates, such as Brentuximab vedotin;
- checkpoint inhibitors, including Nivolumab and Pembrolizumab;
- biological treatments that develop antibodies that destroy malignant cells.
Stem cell transplantation
If Hodgkin's lymphoma does not respond to treatment, stem cell transplantation is recommended in Israel and Germany. Transplants can be autologous (stem cells taken from a patient) or allogeneic (stem cells from a donor). This method helps to stimulate the growth of healthy bone marrow after removal of malignant cells using chemotherapy or radiation.
